Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment
Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment
Not yet recruiting · NCT07201675 · Registry updated 2025-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment | Muscle Invasive Bladder Cancer (MIBC) | Not yet recruiting | Phase 2 | 2025-10-01 | NCT07201675 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Hospital of Shandong University | 249 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||